Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
ACS Nano
|
April 4, 2026
Single-Cell Sequencing Analysis-Driven Nanomedicine Design for Mimicking Endogenous Immune Repair in Myocardial Infarction
Buayishamu Kutilike, Xueqi Lv, Yuqing Gong, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
April 12, 2022
Quantitative methods and modeling to assess COVID-19-interrupted in vivo pharmacokinetic bioequivalence studies with two reference batches
Yuqing Gong, Kairui Feng, Peijue Zhang, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
May 9, 2019
Proteomic Profiling of Exosomes Derived from Plasma of HIV-Infected Alcohol Drinkers and Cigarette Smokers
Sunitha Kodidela, Yujie Wang, Benjamin J Patters, et al.
Clinical Pharmacology and Therapeutics
|
January 18, 2025
A 2024 Update on US FDA Implementation of Partial Area Under the Curve Into Bioavailability and Bioequivalence Assessments
Robert Hopefl, Yuqing Gong, Elizabeth Bielski, et al.
The AAPS Journal
|
April 24, 2024
Application of Advanced Modeling Approaches Supporting Generic Product Development Under GDUFA for Fiscal Year 2023
Eleftheria Tsakalozou, Yuqing Gong, Andrew Babiskin, et al.
Cell Reports
|
August 1, 2023
FRMD8 targets both CDK4 activation and RB degradation to suppress colon cancer growth
Miao Yu, Weijie Wu, Yi Sun, et al.
Elife
|
April 11, 2025
Loss function of tumor suppressor FRMD8 confers resistance to tamoxifen therapy via a dual mechanism
Weijie Wu, Miao Yu, Qianchen Li, et al.
Plos Pathogens
|
January 11, 2021
Red-light is an environmental effector for mutualism between begomovirus and its vector whitefly
Pingzhi Zhao, Xuan Zhang, Yuqing Gong, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 30, 2023
Establishing the suitability of model-integrated evidence to demonstrate bioequivalence for long-acting injectable and implantable drug products: Summary of workshop
Yuqing Gong, Peijue Zhang, Miyoung Yoon, et al.
Science Advances
|
July 3, 2024
Tumor suppressor FRMD3 controls mammary epithelial cell fate determination via notch signaling pathway
Ji Ma, Yuqing Gong, Xiaoran Sun, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
ACS Nano
|
April 4, 2026
Single-Cell Sequencing Analysis-Driven Nanomedicine Design for Mimicking Endogenous Immune Repair in Myocardial Infarction
Buayishamu Kutilike, Xueqi Lv, Yuqing Gong, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
April 12, 2022
Quantitative methods and modeling to assess COVID-19-interrupted in vivo pharmacokinetic bioequivalence studies with two reference batches
Yuqing Gong, Kairui Feng, Peijue Zhang, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
May 9, 2019
Proteomic Profiling of Exosomes Derived from Plasma of HIV-Infected Alcohol Drinkers and Cigarette Smokers
Sunitha Kodidela, Yujie Wang, Benjamin J Patters, et al.
Clinical Pharmacology and Therapeutics
|
January 18, 2025
A 2024 Update on US FDA Implementation of Partial Area Under the Curve Into Bioavailability and Bioequivalence Assessments
Robert Hopefl, Yuqing Gong, Elizabeth Bielski, et al.
The AAPS Journal
|
April 24, 2024
Application of Advanced Modeling Approaches Supporting Generic Product Development Under GDUFA for Fiscal Year 2023
Eleftheria Tsakalozou, Yuqing Gong, Andrew Babiskin, et al.
Cell Reports
|
August 1, 2023
FRMD8 targets both CDK4 activation and RB degradation to suppress colon cancer growth
Miao Yu, Weijie Wu, Yi Sun, et al.
Elife
|
April 11, 2025
Loss function of tumor suppressor FRMD8 confers resistance to tamoxifen therapy via a dual mechanism
Weijie Wu, Miao Yu, Qianchen Li, et al.
Plos Pathogens
|
January 11, 2021
Red-light is an environmental effector for mutualism between begomovirus and its vector whitefly
Pingzhi Zhao, Xuan Zhang, Yuqing Gong, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 30, 2023
Establishing the suitability of model-integrated evidence to demonstrate bioequivalence for long-acting injectable and implantable drug products: Summary of workshop
Yuqing Gong, Peijue Zhang, Miyoung Yoon, et al.
Science Advances
|
July 3, 2024
Tumor suppressor FRMD3 controls mammary epithelial cell fate determination via notch signaling pathway
Ji Ma, Yuqing Gong, Xiaoran Sun, et al.
Page
of 6